Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Colorcon
Merck
Fuji
Baxter
Mallinckrodt
Dow
Chinese Patent Office
Harvard Business School

Generated: December 12, 2018

DrugPatentWatch Database Preview

Litigation for Patent 9,102,723

« Back to Dashboard

US Court Litigation for Patent: 9,102,723

Patent Case Name Docket Date Filed Date Terminated Cause Court Jury Demand Link To Docket
9,102,723 AbbVie Inc. v. Amgen Inc. ➤ Sign Up 2016-08-04 2017-09-28 35:271 Patent Infringement District Court, D. Delaware None ➤ Sign Up
9,102,723 ➤ Sign Up ➤ Sign Up 2018-08-10 35:271 Patent Infringement District Court, D. New Jersey None ➤ Sign Up
Patent Case Name Docket Date Filed Date Terminated Cause Court Jury Demand Link To Docket

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
US Army
Healthtrust
Daiichi Sankyo
Express Scripts
Deloitte
Cerilliant
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.